CLENE NANOMEDICINE

clene-nanomedicine-logo

Clene Nanomedicine is a clinical-stage biopharmaceutical company that focuses on the development of unique therapeutics for neurodegenerative diseases. The company innovated a novel nanotechnology drug platform for the development of a new class of orally-administered neurotherapeutic drugs.

#SimilarOrganizations #People #Financial #Website #More

CLENE NANOMEDICINE

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
2013-01-01

Address:
Salt Lake City, Utah, United States

Country:
United States

Website Url:
http://www.clene.com

Total Employee:
11+

Status:
Active

Contact:
801-676-9695

Email Addresses:
[email protected]

Total Funding:
121.9 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

accera-logo

Accera

Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases.

aclipse-therapeutics-logo

Aclipse Therapeutics

Aclipse Therapeutics focuses on developing differentiated drugs to address diseases with unmet medical needs.

actuate-therapeutics-logo

Actuate Therapeutics

Actuate Therapeutics provides advancing research to treatment of high impact cancers and neurodegenerative diseases.

adagio-medical-logo

Adagio Medical

Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

anjarium-biosciences-logo

Anjarium Biosciences

Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

aprea-logo

Aprea

Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.

dyne-therapeutics-logo

Dyne Therapeutics

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

fimecs-logo

Fimecs

FIMECS is a focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases.

hebecell-logo

HebeCell

HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.

impact-biomedicines-logo

Impact Biomedicines

Impact Biomedicines is pioneering the development of life-changing treatments for patients.

kalgene-pharmaceuticals-logo

KalGene Pharmaceuticals

KalGene Pharmaceuticals is a biotech company that develops precision medicine therapeutics for patients suffering from Alzheimer's disease.

lsk-biopharma-logo

LSK BioPharma

LSK BioPharma specializes in clinical development of promising therapies for unmet medical needs in cancer.

mojave-pharma-logo

Mojave Pharma

Mojave Pharma focuses on the research of novel therapies for neurodegenerative & psychiatric diseases.

neurimmune-holding-logo

Neurimmune Holding

Neurimmune develops innovative immunotherapeutics for human diseases.

neurotrope-bioscience-logo

Neurotrope Bioscience

Neurotrope Bioscience engages in the development of diagnostic and therapeutic technologies for the treatment of neurodegenerative diseases.

not_available_image

Open Innovation Partners

Open Innovation Partners focuses on the development of cancer therapeutic agents.

pharmatrophix-logo

PharmatrophiX

PharmatrophiX is a biotech company focused on developing therapeutic drugs to prevent neurodegenerative diseases.

qlaris-bio-logo

Qlaris Bio

Qlaris Bio focuses on developing novel and innovative therapies for serious and debilitating ophthalmic diseases.

not_available_image

QureBio

QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals.

sorrento-therapeutics-logo

Sorrento Therapeutics

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

spinogenix-logo

Spinogenix

Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.

synaps-dx-logo

Synaps Dx

Synaps Dx focuses on the research, development and commercialization for neurodegenerative disorders including Alzheimerโ€™s Disease.

synapse-medicine-logo

Synapse Medicine

Synapse Medicine offers a medication intelligence platform for healthcare professionals.

tabomedex-biosciences-inc-logo

Tabomedex Biosciences, Inc.

Tabomedex focuses on the R&D of new drugs related to type 2 diabetes.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

ultragenyx-pharmaceutical-logo

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

versameb-logo

Versameb

Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.

allovir-logo

AlloVir

AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.

westlake-therapeutics-logo

Westlake Therapeutics

The company is committed to the development of a variety of innovative cell therapy products for rare diseases, cancer, etc.

Current Employees Featured

mark-mortenson_image

Mark Mortenson
Mark Mortenson Founder @ Clene Nanomedicine
Founder

michael-hotchkin_image

Michael Hotchkin
Michael Hotchkin Chief Development Officer @ Clene Nanomedicine
Chief Development Officer
2017-10-01

robert-glanzman_image

Robert Glanzman
Robert Glanzman Chief Medical Officer @ Clene Nanomedicine
Chief Medical Officer
2019-06-01

rob-etherington_image

Rob Etherington
Rob Etherington CEO @ Clene Nanomedicine
CEO
2013-04-01

ted-jeong_image

Ted Jeong
Ted Jeong Chief Financial Officer @ Clene Nanomedicine
Chief Financial Officer
2020-01-01

Founder


mark-mortenson_image

Mark Mortenson

Stock Details


Company's stock symbol is NASDAQ:CLNN

Investors List

maryland-department-of-housing-and-community-development_image

Maryland Department of Housing and Community Development

Maryland Department of Housing and Community Development investment in Grant - Clene Nanomedicine

symbiosis-ii-llc_image

SymBiosis LLC

SymBiosis LLC investment in Post-IPO Equity - Clene Nanomedicine

symbiosis-ii-llc_image

SymBiosis LLC

SymBiosis LLC investment in Series D - Clene Nanomedicine

national-multiple-sclerosis-society_image

National Multiple Sclerosis Society (NMSS)

National Multiple Sclerosis Society (NMSS) investment in Grant - Clene Nanomedicine

fightmnd_image

FightMND

FightMND investment in Grant - Clene Nanomedicine

Official Site Inspections

http://www.clene.com Semrush global rank: 3.38 M Semrush visits lastest month: 4.65 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Clene Nanomedicine" on Search Engine